Visus Therapeutics

Closed

Vision Restoration for Presbyopia, Cataracts, and Geographic Atrophy | Tenpoint Therapeutics™

Visus Therapeutics is headquartered in Warren, United States and lists 11–50 employees.

Headquarters
Warren, New Jersey
Employees
11–50
Business Model
B2B

About

Visus Therapeutics, Inc. is a Warren, New Jersey-based ophthalmic pharmaceutical company developing paradigm-shifting therapeutics for vision conditions with significant unmet medical need, including presbyopia, cataracts, and geographic atrophy. The company's lead product, YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution), targets presbyopia — a gradual loss of near visual acuity affecting millions of aging adults. Visus Therapeutics operates as an affiliate of Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic company. The company works in partnership with eye care professionals including optometrists and ophthalmologists.

Summary

Visus Therapeutics is a Biotech company based in Warren, United States. It lists 11–50 employees.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Visus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/visus-therapeutics"><img src="https://indexed.vc/api/badge/company/visus-therapeutics" alt="Visus Therapeutics on Indexed.vc" width="260" height="76" /></a>